Stay updated on Expanded Access Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.

Latest updates to the Expanded Access Risdiplam in SMA Clinical Trial page
- Check6 days agoChange DetectedA sitewide NIH notice about terminology changes under Executive Order 14434 was added. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoChange DetectedThe error page’s displayed site revision was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content. The change removes the previously visible study details and related terms, leaving only site chrome and the footer.SummaryDifference15%

- Check62 days agoChange DetectedThe Study Record Dates now display Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor page metadata update without substantive changes to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This reflects an internal update/quality-control revision rather than substantive changes to the study information.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor update to the page's versioning metadata rather than changes to the study details or visible content.SummaryDifference0.1%

Stay in the know with updates to Expanded Access Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.